Cargando…

Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects

BACKGROUND: Benzodiazepines carry the risk of inducing cognitive impairments, which may go unnoticed while profoundly disturbing social activity. Furthermore, these impairments are partly associated with the elimination half-life (EH) of the substance from the body. The object of the present study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukami, Goro, Hashimoto, Tasuku, Shirayama, Yukihiko, Hasegawa, Tadashi, Watanabe, Hiroyuki, Fujisaki, Mihisa, Hashimoto, Kenji, Iyo, Masaomi
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991318/ https://www.ncbi.nlm.nih.gov/pubmed/21047414 http://dx.doi.org/10.1186/1744-859X-9-37

Ejemplares similares

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010)

Ethyl loflazepate as a treatment for patients with idiopathic and psychogenic taste disorder
por: Sakata, Ken-ichiro, et al.
Publicado: (2022)

Expert consensus on hospitalization for assessment: a survey in Japan for a new forensic mental health system
por: Shiina, Akihiro, et al.
Publicado: (2011)

Perception of and anxiety about COVID-19 infection and risk behaviors for spreading infection: an international comparison
por: Shiina, Akihiro, et al.
Publicado: (2021)

Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial
por: Hashimoto, Tasuku, et al.
Publicado: (2016)

Serum glutamine, set-shifting ability and anorexia nervosa
por: Nakazato, Michiko, et al.
Publicado: (2010)

An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2015)

A case of etizolam dependence
por: Gupta, Sumit, et al.
Publicado: (2014)

PS64. Psychiatrists' thinking about how to prescribe psychotropic drugs in out-patients with major depressive disorder and bipolar disorder in general clinical practice compared to the evidence-based guidelines.
por: Koseki, Maiko, et al.
Publicado: (2016)

Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2012)

Correction: Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2013)

Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
por: Shirayama, Yukihiko, et al.
Publicado: (2017)

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study
por: Hashimoto, Tasuku, et al.
Publicado: (2015)

Recognition of change in the reform of forensic mental health by clinical practitioners: a questionnaire survey in Japan
por: Shiina, Akihiro, et al.
Publicado: (2014)

Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T (1)H-MRS Study
por: Matsuzawa, Daisuke, et al.
Publicado: (2008)

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia
por: Oda, Yasunori, et al.
Publicado: (2015)

Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer’s disease: a preliminary study
por: Tsuruoka, Yoshiaki, et al.
Publicado: (2016)

Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study
por: Sasaki, Tsuyoshi, et al.
Publicado: (2014)

Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine
por: Hagiwara, Hiroko, et al.
Publicado: (2013)

Treatment of refractory catatonic schizophrenia with low dose aripiprazole
por: Sasaki, Tsuyoshi, et al.
Publicado: (2012)

Psychological Distress Symptoms Associated With Life Events in Patients With Bipolar Disorder: A Cross-Sectional Study
por: Sato, Aiko, et al.
Publicado: (2018)

The adulterated XANAX pill: a fatal intoxication with etizolam and caffeine
por: Kolbe, V., et al.
Publicado: (2020)

Treatment of concurrent etizolam and tianeptine withdrawal following accidental overdose
por: Markovic, Marija, et al.
Publicado: (2023)

Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study
por: Sasaki, Tsuyoshi, et al.
Publicado: (2014)

Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP(3) Receptors and Cellular Signaling Pathways
por: Nishimura, Tomoko, et al.
Publicado: (2008)

PM365. Effects of sulforaphane in the maternal immune activation model of schizophrenia
por: Matsuura, Akiko, et al.
Publicado: (2016)

High-Dose Dependence and Cognitive Side Effects to Medical Prescription of Etizolam
por: Tamburin, Stefano, et al.
Publicado: (2020)

Relationship between perception and anxiety about COVID-19 infection and risk behaviors for spreading infection: A national survey in Japan
por: Shiina, Akihiro, et al.
Publicado: (2020)

A pilot trial of an online guided self-help cognitive behavioral therapy program for bulimia nervosa and binge eating disorder in Japanese patients
por: Ohsako, Noriaki, et al.
Publicado: (2023)

Metabolic Profile Analysis of Designer Benzodiazepine Etizolam in Zebrafish and Human Liver Microsomes
por: Jie, Zhaowei, et al.
Publicado: (2023)

Etizolam Blood Concentrations in 191 Forensic Cases in Ontario, Canada (2019–2020)
por: Watts, Christena, et al.
Publicado: (2021)

Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder
por: Tadokoro, Shigenori, et al.
Publicado: (2011)

Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report
por: Tadokoro, Shigenori, et al.
Publicado: (2017)

Regional Differences in Brain-Derived Neurotrophic Factor Levels and Dendritic Spine Density Confer Resilience to Inescapable Stress
por: Yang, Chun, et al.
Publicado: (2015)

Possible effect of blonanserin on gambling disorder: A clinical study protocol and a case report
por: Shiina, Akihiro, et al.
Publicado: (2021)

Intraperitoneal Administration of Etizolam Improves Locomotor Function in Mice After Spinal Cord Injury
por: Saruta, Kenya, et al.
Publicado: (2023)

A Study of Remitted and Treatment-Resistant Depression Using MMPI and Including Pessimism and Optimism Scales
por: Suzuki, Masatoshi, et al.
Publicado: (2014)

Low Openness on the Revised NEO Personality Inventory as a Risk Factor for Treatment-Resistant Depression
por: Takahashi, Michio, et al.
Publicado: (2013)

Personality Traits as Risk Factors for Treatment-Resistant Depression
por: Takahashi, Michio, et al.
Publicado: (2013)

Increased Serum Levels of Oxytocin in ‘Treatment Resistant Depression in Adolescents (TRDIA)’ Group
por: Sasaki, Tsuyoshi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a5m6o3g9irffeh9v5uctsrhh7k